ArticleCancers2019

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers.

Tarek M A Abdel-Fatah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.